Northern Trust’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-17,074
| Closed | -$7.26K | – | 4698 |
|
|
2022
Q4 | $7.26K | Hold |
17,074
| – | – | ﹤0.01% | 4606 |
|
|
2022
Q3 | $12K | Hold |
17,074
| – | – | ﹤0.01% | 4630 |
|
|
2022
Q2 | $11K | Hold |
17,074
| – | – | ﹤0.01% | 4689 |
|
|
2022
Q1 | $18K | Hold |
17,074
| – | – | ﹤0.01% | 4679 |
|
|
2021
Q4 | $19K | Sell |
17,074
-246
| -1% | -$452 | ﹤0.01% | 4711 |
|
|
2021
Q3 | $40K | Sell |
17,320
-848
| -5% | -$2.13K | ﹤0.01% | 4562 |
|
|
2021
Q2 | $54K | Buy |
+18,168
| New | +$51.1K | ﹤0.01% | 4486 |
|
|
2020
Q4 | – | Sell |
-2,296
| Closed | -$12K | – | 4430 |
|
|
2020
Q3 | $12K | Buy |
+2,296
| New | +$13.3K | ﹤0.01% | 4253 |
|
|
2019
Q3 | – | Sell |
-75
| Closed | -$28K | – | 4307 |
|
|
2019
Q2 | $28K | Hold |
75
| – | – | ﹤0.01% | 4141 |
|
|
2019
Q1 | $70K | Buy |
75
+13
| +21% | +$13.8K | ﹤0.01% | 3987 |
|
|
2018
Q4 | $65K | Hold |
62
| – | – | ﹤0.01% | 4006 |
|
|
2018
Q3 | $167K | Sell |
62
-2
| -3% | -$5.67K | ﹤0.01% | 3905 |
|
|
2018
Q2 | $174K | Sell |
64
-189
| -75% | -$545K | ﹤0.01% | 3896 |
|
|
2018
Q1 | $926K | Buy |
253
+77
| +44% | +$335K | ﹤0.01% | 3397 |
|
|
2017
Q4 | $877K | Sell |
176
-3
| -2% | -$15.6K | ﹤0.01% | 3437 |
|
|
2017
Q3 | $937K | Buy |
179
+16
| +10% | +$98.6K | ﹤0.01% | 3453 |
|
|
2017
Q2 | $1.17M | Buy |
+163
| New | +$1.21M | ﹤0.01% | 3404 |
|
Other funds holding VIVE
Northern Trust's VIVE Position: Q1 2023 in Review
Northern Trust sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 17,074 shares — an estimated $7.26K sold.
Northern Trust first reported a position in VIVE in Q2 2017 and held it in 17 quarters. The position peaked at $1.17M in Q2 2017. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.
- Northern Trust reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
- Northern Trust sold 17,074 VIVEVE MED INC shares in Q1 2023, an estimated $7.26K.
- Northern Trust first reported a position in VIVEVE MED INC in Q2 2017 and held it in 17 quarters.
- Northern Trust's VIVEVE MED INC position peaked at $1.17M in Q2 2017.
- 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.
Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.